Top 10 search results for "" in Treatments. To see all results and access other features, sign up for free.

Ojjaara (Momelotinib)

Overview
Ojjaara is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with myelofibrosis (MF) and anemia (low red blood cell count). Ojjaara may be recommended to treat… read more

Inrebic (Fedratinib)

Overview
Inrebic is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with intermediate or high-risk primary or secondary myelofibrosis, a cancer of the bone marrow. Inrebic is… read more

Gleevec (Imatinib Mesylate)

Overview
Gleevec is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults and children with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) — a type of … read more

Tasigna (Nilotinib)

Overview
Tasigna is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) — a type of myeloproliferative… read more

Sprycel (Dasatinib)

Overview
Sprycel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with:
• Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia… read more

Jakafi (Ruxolitinib)

Overview
Jakafi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera… read more

Vonjo (Pacritinib)

Overview
Vonjo is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain types of myelofibrosis. Vonjo is also known by its generic name, pacritinib.

Vonjo is… read more

Phyrago (Dasatinib)

Overview
Phyrago is approved by the U.S. Food and Drug Administration (FDA) to treat chronic myeloid leukemia (CML), a type of blood cancer that belongs to a group called myeloproliferative neoplasms (MPNs). Phyrago is…

Synribo (Omacetaxine Mepesuccinate)

Overview
Synribo is approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic or accelerated-phase chronic myeloid leukemia (CML) who have developed resistance or intolerance to at least two…

Besremi (Ropeginterferon Alfa-2b)

Overview
Besremi is approved by the U.S. Food and Drug Administration (FDA) specifically for the treatment of polycythemia vera (PV), a type of myeloproliferative neoplasm characterized by the overproduction of red blood…

myMPNteam is the social network for those living with myeloproliferative neoplasms. Get the emotional support you need from others like you, and gain practical advice and insights on managing treatment or therapies for myeloproliferative neoplasms. myMPNteam is the only social network where you can truly connect, make real friendships, and share daily ups and downs in a judgement-free place.

myMPNteam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment. No information on myMPNteam should be construed as medical and/or health advice.

Connect with others who understand.